PDL guidance on the AstraZeneca COVID-19 vaccine
July 7, 2021
The PDL Professional Officers have received several calls relating to the administration of the AstraZeneca (AZ) vaccine in patients below 60 years of age. Whilst
The PDL Professional Officers have received several calls relating to the administration of the AstraZeneca (AZ) vaccine in patients below 60 years of age. Whilst
From 1st February 2021, prescribers are required to include the active ingredient on all PBS and RPBS prescriptions. A transition period has been granted for
PDL reminds all members that Ahpra renewal of registration is due by the end of this month (November 2020). We offer this reminder as PDL
PDL has spoken with many pharmacists impacted by the changes to S3 supply requirements for salbutamol inhalers made by TGA earlier this year. These changes
Pharmacists may be aware of the Urinary Tract Infection Pharmacy Pilot – Queensland (UTIPP-Q) program. The UTIPP-Q program is a research pilot program to investigate
1. Compare the millilitres vs milligrams dose Mixtures expressed in mg/ml are frequently implicated in dispensing errors reported to PDL. Examples of mixtures that seem
Victorian Pharmacist-Administered Vaccination Program People aged 10 years and older will be able to receive their influenza vaccine from a Pharmacist Immuniser. People aged 15
Pharmacists breaching regulations involving opioid replacement therapy (ORT) are quickly referred to the regulators. A recent blitz from NSW Health against pharmacies that provide opioid-replacement services is resulting
At the end of the My Health Record (MHR) opt-out period the Government ranks the participation rate as 90.1%. Healthcare providers are under no obligation
From 1 February 2018 medicines containing codeine will no longer be available without a prescription due to the Therapeutic Goods Administration (TGA) up-schedule. The imminent